Jds Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JDS PHARMS, and what generic and branded alternatives to JDS PHARMS drugs are available?
JDS PHARMS has two approved drugs.
Summary for Jds Pharms
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Jds Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jds Pharms | ESKALITH | lithium carbonate | TABLET;ORAL | 017971-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Jds Pharms | ESKALITH CR | lithium carbonate | TABLET, EXTENDED RELEASE;ORAL | 018152-001 | Mar 29, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
